scispace - formally typeset
Open AccessJournal ArticleDOI

Science, medicine, and the future: Leishmaniasis

Reads0
Chats0
TLDR
The leishmania genome project as discussed by the authors was the first attempt to sequence part of each of the transcripts of all the genes of the organism, and the plan is now to sequence its entire genome.
Abstract
Leishmaniasis constitutes a diverse collection of human diseases ranging in severity from a spontaneously healing skin ulcer to overwhelming visceral disease. Worldwide, two million new cases occur each year, and a 10th of the world's population is at risk of infection.1 Although the disease is highly endemic throughout northern Africa, the Middle East, parts of Europe, and Central and South America, epidemics are well recognised. For example, in southern Sudan more than 10% of the population died from visceral leishmaniasis over the past five years. Outcome of infection is determined by interactions between the host and parasite, which are governed by the genomes of the host and parasite. It is therefore exciting to see that both host and parasite genomes have been targeted for sequence analysis.2 The leishmania genome project began as a large scale attempt to sequence part of each of the transcripts of all the genes of the organism, and the plan is now to sequence its entire genome. The genetic information from both human and parasite and the emergence of new tools such as microarray technologies will allow us to gain an understanding of the interaction between parasite virulence factors and host response factors. Molecular knowledge of the host-parasite interaction will facilitate targeting of new treatments. We chose topics for this article to convey the impact that current research will have on the pathophysiology and treatment of leishmaniasis. We used a variety of sources for the topics, including published original articles and reviews, the internet, and personal communications. ### Epidemiology Leishmaniasis results from an infection with the protozoan parasite Leishmania spp. The organism is transmitted to humans by the bite of the sandfly.1 Humans are usually accidental hosts of these 2 mm long flies; natural hosts include a variety of rodents, small mammals, and dogs. Disease …

read more

Citations
More filters
Journal ArticleDOI

Leishmaniasis: Current Status of Vaccine Development

TL;DR: A major vaccine development program aimed initially at cutaneous leishmaniasis is under way, and focuses on new adjuvants, including cytokines, and delivery systems to target the T helper type 1 immune responses required for the elimination of this intracellular organism.
Journal ArticleDOI

Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature.

TL;DR: Crusted scabies often occurs in patients with identifiable immunosuppressive risk factors and in patients without such risk factors, it is possible that the crusted response to infection results from a tendency to preferentially mount a Th2 response.
Journal ArticleDOI

Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light

TL;DR: The intent of this study was to examine the ability of the Mirasol PRT System to kill the Leishmania parasite in human plasma and platelet concentrates.
Journal ArticleDOI

Leishmaniasis, an emerging disease found in companion animals in the United States.

TL;DR: Leishmaniasis is endemic in Foxhound populations in the United States and is still being characterized in this group, and pathophysiology, clinical signs, transmission, immunology, and treatment are examined in this review.
Journal ArticleDOI

Immunologic indicators of clinical progression during canine Leishmania infantum infection.

TL;DR: The temporal immune response to natural autochthonous L. infantum infection in foxhounds within the United States is described for the first time and the immuno-dysregulation mirror those observed in human patients, indicating this animal model will be very useful for testing immunomodulatory anti-IL-10 and other therapies.
References
More filters
Journal Article

Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

TL;DR: A panel of antigen-specific mouse helper T cell clones was characterized according to patterns of lymphokine activity production, and two types of T cell were distinguished.
Journal ArticleDOI

Functional diversity of helper T lymphocytes.

TL;DR: The existence of subsets of CD4+ helper T lymphocytes that differ in their cytokine secretion patterns and effector functions provides a framework for understanding the heterogeneity of normal and pathological immune responses.
Journal ArticleDOI

The expanding universe of T-cell subsets: Th1, Th2 and more

TL;DR: The increasing number of T-cell subsets defined by cytokine patterns; the differentiation pathways of CD4+ and CD8+ T cells; the contribution of other cell types to these patterns; and the cytokine interactions during infection and pregnancy are discussed.
Journal ArticleDOI

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.

TL;DR: The inverse relationship of IFN-gamma and IL-4 gene expression during leishmaniasis may underlie the divergence of cellular and humoral immunity that occurs during chronic infection with Leishmania and possibly other intracellular parasites.
Journal ArticleDOI

Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans.

TL;DR: Genetic variation in NRAMP1 affects susceptibility to tuberculosis in West Africans, and subjects who were heterozygous for twoNRAMP1 polymorphisms in intron 4 and the 3' untranslated region of the gene were particularly overrepresented among those with tuberculosis.
Related Papers (5)